Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 4, 2011 - Issue 6
Submit an article Journal homepage
253
Views
18
CrossRef citations to date
0
Altmetric
Drug Profile

Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus

John E Gerich University of Rochester, School of Medicine, Rochester, NY 14642, USA. [email protected]; 403 Woodcrest Road, Wayne, PA 19087, USA; University of Rochester, School of Medicine, Rochester, NY 14642, USA. [email protected]; 403 Woodcrest Road, Wayne, PA 19087, USA
&
Arnaud Bastien Global Clinical Research, Bristol-Myers Squibb, Princeton, NJ, USA; Global Clinical Research, Bristol-Myers Squibb, Princeton, NJ, USA
Pages 669-683 | Published online: 10 Jan 2014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.